B Nickel

1.1k total citations
42 papers, 952 citations indexed

About

B Nickel is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, B Nickel has authored 42 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cellular and Molecular Neuroscience, 14 papers in Molecular Biology and 12 papers in Physiology. Recurrent topics in B Nickel's work include Neurotransmitter Receptor Influence on Behavior (12 papers), Neuroscience and Neuropharmacology Research (10 papers) and Pain Mechanisms and Treatments (9 papers). B Nickel is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (12 papers), Neuroscience and Neuropharmacology Research (10 papers) and Pain Mechanisms and Treatments (9 papers). B Nickel collaborates with scholars based in Germany, United States and France. B Nickel's co-authors include Istvan Szelenyi, Helmut Harms, Peter Emig, Ulrich Finckh, Jan Podschus, T. Klenner, Thomas Beckers, Gerald Bacher, M. Spüler and Wilfried Dimpfel and has published in prestigious journals such as Biological Psychiatry, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

B Nickel

42 papers receiving 886 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B Nickel Germany 18 428 385 174 161 114 42 952
Takeo Fukuda Japan 19 466 1.1× 289 0.8× 222 1.3× 158 1.0× 148 1.3× 80 1.2k
Jean‐Marie Gillardin France 18 323 0.8× 248 0.6× 205 1.2× 56 0.3× 66 0.6× 31 840
Aron D. Mosnaim United States 20 378 0.9× 351 0.9× 205 1.2× 101 0.6× 110 1.0× 85 1.3k
James A. Totaro United States 19 730 1.7× 458 1.2× 225 1.3× 93 0.6× 184 1.6× 34 1.4k
Saizo YANAURA Japan 17 525 1.2× 254 0.7× 304 1.7× 72 0.4× 53 0.5× 201 1.1k
Hyacinth C. Akunne United States 24 1.0k 2.4× 925 2.4× 107 0.6× 248 1.5× 69 0.6× 49 1.5k
Bjarne Fjalland Denmark 18 520 1.2× 376 1.0× 131 0.8× 61 0.4× 49 0.4× 45 1.0k
A. Sundwall Sweden 18 486 1.1× 378 1.0× 104 0.6× 85 0.5× 87 0.8× 46 1.0k
John S. Andrews United States 19 503 1.2× 650 1.7× 127 0.7× 54 0.3× 71 0.6× 45 1.6k
M. N. Subhash India 18 318 0.7× 250 0.6× 105 0.6× 91 0.6× 82 0.7× 46 870

Countries citing papers authored by B Nickel

Since Specialization
Citations

This map shows the geographic impact of B Nickel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Nickel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Nickel more than expected).

Fields of papers citing papers by B Nickel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Nickel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Nickel. The network helps show where B Nickel may publish in the future.

Co-authorship network of co-authors of B Nickel

This figure shows the co-authorship network connecting the top 25 collaborators of B Nickel. A scholar is included among the top collaborators of B Nickel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Nickel. B Nickel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bacher, Gerald, B Nickel, Peter Emig, et al.. (2001). D-24851, a novel synthetic microtubule inhibitor, exerts curative antitumoral activity in vivo, shows efficacy toward multidrug-resistant tumor cells, and lacks neurotoxicity.. PubMed. 61(1). 392–9. 131 indexed citations
2.
Marchand, Pascal, et al.. (2001). 強力鎮痛薬としての(インドール‐3‐イル)アルキルアミド類の合成と薬理学的評価. 51(10). 814–824. 1 indexed citations
3.
Sander, Thomas, Helmut Harms, Jan Podschus, et al.. (1997). Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biological Psychiatry. 41(3). 299–304. 122 indexed citations
4.
Göthert, Manfred, M. Hamon, Martin Barann, et al.. (1995). 5‐HT3 receptor antagonism by anpirtoline, a mixed 5‐HT1 receptor agonist/5‐HT3 receptor antagonist. British Journal of Pharmacology. 114(2). 269–274. 12 indexed citations
5.
Sander, T., Helmut Harms, Jan Podschus, et al.. (1995). Dopamine D1, D2 and D3 receptor genes in alcohol dependence. Psychiatric Genetics. 5(4). 171–176. 82 indexed citations
6.
Nickel, B, et al.. (1994). Evaluation of physical dependence liability of l-deprenyl (selegiline) in animals*. Clinical Pharmacology & Therapeutics. 56(6 Pt 2). 757–767. 9 indexed citations
7.
Nagymajtényi, László, B Nickel, I. Dési, & Istvan Szelenyi. (1992). Influence of flupirtine, a novel nonopioid analgesic agent on somatosensory evoked potentials in rats. Cellular and Molecular Life Sciences. 48(10). 992–993. 1 indexed citations
8.
Swedberg, Michael D.B., et al.. (1992). D-16949 (anpirtoline): a novel serotonergic (5-HT1B) psychotherapeutic agent assessed by its discriminative effects in the rat.. Journal of Pharmacology and Experimental Therapeutics. 263(3). 1015–1022. 22 indexed citations
9.
Haas, Wolfgang & B Nickel. (1991). THE VALUE OF BRAINSTEM AUDITORY EVOKED POTENTIALS IN EARLY DIAGNOSIS OF WERNICKE'S ENCEPHALOPATHY. Alcohol and Alcoholism. 26(2). 115–119. 16 indexed citations
10.
Nickel, B, Harald O. Borbe, & Istvan Szelenyi. (1990). Effect of selegiline and desmethyl-selegiline on cortical electric activity in rats. PubMed. 32. 139–144. 3 indexed citations
11.
Borbe, Harald O., G Niebch, & B Nickel. (1990). Kinetic evaluation of MAO-B-activity following oral administration of selegiline and desmethyl-selegiline in the rat. PubMed. 32. 131–137. 20 indexed citations
12.
Thiele, H.‐G., et al.. (1990). Cortisol and β-endorphin response in alcoholics and alcohol abusers following a high naloxone dosage. Drug and Alcohol Dependence. 25(3). 319–326. 31 indexed citations
13.
Nickel, B, et al.. (1990). Effect of enantiomers of deprenyl (selegiline) and amphetamine on physical abuse liability and cortical electrical activity in rats. Neuropharmacology. 29(11). 983–992. 17 indexed citations
14.
Vaupel, D. Bruce, B Nickel, & K. Becketts. (1989). Flupirtine antinociception in the dog is primarily mediated by nonopioid supraspinal mechanisms. European Journal of Pharmacology. 162(3). 447–456. 7 indexed citations
15.
Nickel, B & Istvan Szelenyi. (1989). Comparison of changes in the EEG of freely moving rats induced by enciprazine, buspirone and diazepam. Neuropharmacology. 28(8). 799–803. 27 indexed citations
16.
Walter‐Sack, I., et al.. (1989). The influence of different formula diets and different pharmaceutical formulations on the systemic availability of paracetamol, gallbladder size, and plasma glucose.. PubMed. 27(11). 544–50. 14 indexed citations
17.
Swedberg, Michael D.B., et al.. (1988). Pharmacological mechanisms of action of flupirtine: a novel, centrally acting, nonopioid analgesic evaluated by its discriminative effects in the rat.. Journal of Pharmacology and Experimental Therapeutics. 246(3). 1067–1074. 22 indexed citations
18.
Nickel, B, Jutta Engel, & Istvan Szelenyi. (1988). Possible involvement of noradrenergic descending pain-modulating pathways in the mode of antinociceptive action of flupirtine, a novel non-opioid analgesic. Inflammation Research. 23(1-2). 112–116. 11 indexed citations
19.
Dimpfel, Wilfried, M. Spüler, & B Nickel. (1988). Dose- and Time-Dependent Action of Morphine, Tramadol and Flupirtine as Studied by Radioelectroencephalography in the Freely Behaving Rat. Neuropsychobiology. 20(3). 164–168. 15 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takeo Fukuda Breakdown of academic impact, for papers by Jean‐Marie Gillardin Breakdown of academic impact, for papers by Aron D. Mosnaim Breakdown of academic impact, for papers by James A. Totaro Breakdown of academic impact, for papers by Saizo YANAURA Breakdown of academic impact, for papers by Hyacinth C. Akunne Breakdown of academic impact, for papers by Bjarne Fjalland Breakdown of academic impact, for papers by A. Sundwall Breakdown of academic impact, for papers by John S. Andrews Breakdown of academic impact, for papers by M. N. Subhash
Rankless by CCL
2026